Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Veterinary pharmacovigilance. Part 5. Causality and expectedness.

K N Woodward1

  • 1Schering-Plough Animal Health, Uxbridge, Middlesex, UK. kevin.woodward@spcorp.com

Journal of Veterinary Pharmacology and Therapeutics
|April 22, 2005
PubMed
Summary

Determining causality for animal adverse drug reactions can be complex. This study examines causality assessment approaches and algorithms, drawing parallels with human pharmacovigilance for improved decision-making.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Toxicity in animals: target species.

Current pharmaceutical biotechnology·2011
Same author

Assessment of user safety, exposure and risk to veterinary medicinal products in the European Union.

Regulatory toxicology and pharmacology : RTP·2007
Same author

The potential impact of the use of homeopathic and herbal remedies on monitoring the safety of prescription products.

Human & experimental toxicology·2005
Same author

Veterinary pharmacovigilance. Part 1. The legal basis in the European Union.

Journal of veterinary pharmacology and therapeutics·2005
Same author

Veterinary pharmacovigilance. Part 2. Veterinary pharmacovigilance in practice -- the operation of a spontaneous reporting scheme in a European Union country -- the UK, and schemes in other countries.

Journal of veterinary pharmacology and therapeutics·2005
Same author

Veterinary pharmacovigilance. Part 3. Adverse effects of veterinary medicinal products in animals and on the environment.

Journal of veterinary pharmacology and therapeutics·2005

Area of Science:

  • Veterinary Pharmacology
  • Drug Safety Assessment

Background:

  • Regulatory bodies require causality assessment for animal adverse drug reactions.
  • The European Union utilizes the ABON system, but causality assignment can be challenging.
  • Distinguishing expected from unexpected adverse drug reactions is complex, especially across multiple species and breeds.

Purpose of the Study:

  • To examine approaches to causality assessment for adverse drug reactions in animals.
  • To evaluate the utility of algorithms in facilitating causality assessment.
  • To discuss a decision-making framework for adverse drug reactions, referencing human pharmacovigilance.

Main Methods:

  • Review of key criteria for causality assessment, including drug administration timing and biological plausibility.

Related Experiment Videos

  • Examination of algorithms designed to aid the causality assessment process.
  • Discussion of a novel approach adapted from human medicinal product pharmacovigilance.

    • Main Results:

    • Causality assessment relies on criteria such as temporal relationship and biological plausibility.
    • Algorithms can potentially streamline the complex process of causality assignment.
    • A systematic approach, similar to human drug safety, can aid in evaluating adverse events in animals.

    Conclusions:

    • Causality assessment for animal adverse drug reactions requires careful consideration of multiple factors.
    • Algorithmic approaches and human pharmacovigilance models offer valuable tools for improving decision-making.
    • Standardized methodologies are crucial for accurate and consistent reporting of adverse drug reactions in veterinary medicine.